Reports Q4 revenue $561M, consensus $555.14M. “Our performance in 2024 marks a transformational year for the Company as we executed our integration plans and solidified our ability to deliver sustainable high-single-digit organic growth and year-over-year margin expansion,” said Matt Trerotola, CEO of Enovis (ENOV). “Our strong finish in 2024 has set a solid foundation for 2025 with key new product launches positioned to drive above market growth rates.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
- ENOV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Needham medtech & diagnostics analyst holds analyst/industry conference call
- Enovis Highlights Growth at J.P. Morgan Conference
- Closing Bell Movers: Cal-Maine Foods up 5% on Q2 results
- Maplebear to replace Enovis in S&P 400 at open on 1/14